Cryptocurrency & Digital Assets

Get ready for a car that knows you. Cinemo's agentic AI promises hyper-personalized rides, blurring the lines between your vehicle and your digital life.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Johnson & Johnson's TRUFILL n-BCA gains FDA approval for chronic subdural hematoma, offering a minimally invasive option to curb high rates of recurrence.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

As the flex office market heats up, niche providers like Urban W Ltd are adopting advanced proptech to streamline operations and redefine luxury service.

ICL Group's deal to acquire acidulant leader Bartek Ingredients signals a major push into the booming functional food market, leveraging unique production.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Completing a key mission 5 months early, Rocket Lab deployed novel DiskSat tech, cementing its role in the U.S. military's agile space strategy.

Vision Marine secures critical funds for its electric boat ambitions, but the deal's terms raise questions about shareholder value and its financial health.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.

The insurer's routine preferred stock dividend declaration masks a deeper story of record profits, strategic execution, and strong analyst confidence.

At JSHG 2025, Nabsys presents its OhmX platform, a breakthrough in electronic genome mapping that promises to solve rare disease mysteries and advance cancer research.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

IonQ and QuantumBasel expand their partnership to over $60M, aiming to unlock practical quantum solutions for AI, pharma, and logistics across Europe.